Literature DB >> 1544227

Regulation of IL-2 production by mononuclear cells from rheumatoid arthritis synovial fluids.

E Flescher1, T L Bowlin, N Talal.   

Abstract

Products of polyamine oxidation down-regulate IL-2 production by peripheral blood T cells. We show here that the production of IL-2 by rheumatoid arthritis synovial fluid mononuclear cells is inversely correlated with the concentrations of polyamines in these cells. In addition, the inhibition of polyamine biosynthesis or oxidation in cultures of these cells enhances their ability to produce IL-2. Our findings suggest that polyamine oxidation plays an important role in the suppression of T cell function characteristic of rheumatoid arthritis synovial fluids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544227      PMCID: PMC1554338          DOI: 10.1111/j.1365-2249.1992.tb03015.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2- and interleukin-3-dependent cell lines.

Authors:  T L Bowlin; B J McKown; P S Sunkara
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

2.  Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies.

Authors:  M Lotz; C D Tsoukas; C A Robinson; C A Dinarello; D A Carson; J H Vaughan
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 3.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

4.  Polyamine oxidation down-regulates IL-2 production by human peripheral blood mononuclear cells.

Authors:  E Flescher; T L Bowlin; N Talal
Journal:  J Immunol       Date:  1989-02-01       Impact factor: 5.422

5.  Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis.

Authors:  E Flescher; T L Bowlin; A Ballester; R Houk; N Talal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Transforming growth factor-beta and cellular immune responses in synovial fluids.

Authors:  M Lotz; J Kekow; D A Carson
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

7.  Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood.

Authors:  B Combe; R M Pope; M Fischbach; B Darnell; S Baron; N Talal
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

8.  Polyamine oxidase activity in rheumatoid arthritis synovial fluid.

Authors:  A Ferrante; R J Storer; L J Cleland
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

9.  Enzymatic oxidation of polyamines. Relationship to immunosuppressive properties.

Authors:  R S Labib; T B Tomasi
Journal:  Eur J Immunol       Date:  1981-03       Impact factor: 5.532

10.  Prostaglandin E inhibits the production of human interleukin 2.

Authors:  R S Rappaport; G R Dodge
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  4 in total

1.  Polyamine deprivation prevents the development of tumour-induced immune suppression.

Authors:  L Chamaillard; V Catros-Quemener; J G Delcros; J Y Bansard; R Havouis; D Desury; A Commeurec; N Genetet; J P Moulinoux
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

2.  Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages.

Authors:  Kyung-Ran Park; Chul Ju Hwang; Hyung-Mun Yun; In Jun Yeo; Dong-Young Choi; Pil-Hoon Park; Hyung Sook Kim; Jung Tae Lee; Young Suk Jung; Sang-Bae Han; Jin Tae Hong
Journal:  Stem Cell Res Ther       Date:  2020-03-04       Impact factor: 6.832

Review 3.  The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment.

Authors:  Jiachun Lian; Yanfang Liang; Hailiang Zhang; Minsheng Lan; Ziyu Ye; Bihua Lin; Xianxiu Qiu; Jincheng Zeng
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

Review 4.  Molecular action of methotrexate in inflammatory diseases.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Arthritis Res       Date:  2002-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.